Personalized Patient Media Platform: Medication Adherence Meets Pharma Marketing
Program Process At-a-Glance 2. Physician: Invites patient to participate and provides Program Kit 3. Patient: Enrolls and takes first survey via Interactive Voice Response or Web 4. Patient: Takes medication as directed; communicates experience information via follow-up survey(s) 6. Physician & Patient: Receive individualized patient survey reports 5. Patient: Receives education, reminders, other information as appropriate 8. Pharma Brand Team: Receives activity reports, analytic summaries, ROI analyses, & potential medical data publication opportunities 1. Sales Rep: Introduces Physician to the Program 7. Patient and Physician: Establish new and more effective communication during survey results review START
Step 1: Physician Explains Benefits of Program Participation to Patients
Step 2: Patients Complete Surveys Through Preferred Methods at Regular Intervals
Step 3: Patients Receive Reports to Track Their Own Progress
Step 5:Patient and Provider Assess Treatment Progress
Helps to bridge the communication gaps between patients and doctors
Raises awareness of patient’s specific treatment challenges
Increases patient persistency and compliance 17-27% avg. improvement in patient adherence
Builds physician confidence in prescribing decision
Allows pharmaceutical manufacturer to offer meaningful support and valued information
What Do Doctors Think? 93% felt the reports provided new information 82% would encourage patients to participate in these programs 61% would like reports for other medications they prescribe 89% would participate in another program 88% would file the reports in the patient’s chart Source: Internal InfoMedics Data, 2007. Doctors participate because it translates anecdotal patient input into more rigorous medical data to drive guideline-based intervention.
What Do Patients Think? 66% felt the program would help them better communicate with their physicians 77% would participate again in similar programs Patients participate because they want to provide information to their doctor that will help with their treatment, and also to help others who are suffering. Source: Internal InfoMedics Data, 2007.
InfoMedics, Inc. works with biopharmaceutical marketers to break down walls that exist in health communications and enable doctors and patients to better communicate about a treatment experience. We facilitate this communication by inviting patients to provide feedback to their prescribing physician and then deliver that feedback in a meaningful format directly to the physician.
Founded in 1995, InfoMedics has experience in 60 disease categories through work for over 30 biopharmaceutical companies
Platform based on Technology Linked Care (TLC) developed by Dr. Robert Freidman, Boston University School of Medicine
InfoMedics has authored or coauthored over 50 scientific publications on patient medication adherence and behavior